Leavell Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,288
Closed -$205K 385
2018
Q3
$205K Buy
+2,288
New +$202K 0.02% 368
2018
Q1
Sell
-2,077
Closed -$217K 391
2017
Q4
$217K Hold
2,077
0.03% 358
2017
Q3
$303K Sell
2,077
-100
-5% -$13.6K 0.04% 306
2017
Q2
$283K Hold
2,177
0.04% 324
2017
Q1
$271K Hold
2,177
0.03% 321
2016
Q4
$252K Hold
2,177
0.03% 332
2016
Q3
$228K Sell
2,177
-291
-12% -$31.5K 0.03% 343
2016
Q2
$243K Hold
2,468
0.04% 351
2016
Q1
$247K Hold
2,468
0.04% 331
2015
Q4
$296K Buy
2,468
+100
+4% +$11.6K 0.04% 305
2015
Q3
$256K Buy
2,368
+100
+4% +$12.4K 0.04% 334
2015
Q2
$262K Hold
2,268
0.04% 348
2015
Q1
$261K Hold
2,268
0.04% 349
2014
Q4
$254K Buy
+2,268
New +$239K 0.04% 352

Other funds holding CELG

Leavell Investment Management's CELG Position: Q4 2018 in Review

Leavell Investment Management sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,288 shares — an estimated $205K sold.

Leavell Investment Management first reported a position in CELG in Q4 2014 and held it in 14 quarters. The position peaked at $303K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Leavell Investment Management reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Leavell Investment Management sold 2,288 Celgene Corp shares in Q4 2018, an estimated $205K.
  • Leavell Investment Management first reported a position in Celgene Corp in Q4 2014 and held it in 14 quarters.
  • Leavell Investment Management's Celgene Corp position peaked at $303K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Leavell Investment Management's 13F filing for Q4 2018, filed 24 Jan 2019.